Comment on Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know

Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know

With $290 million in funding and a team of industry veterans, the new company hopes to enter a category of obesity treatments that has taken the country by storm. Metsera, a clinical-stage biotechnology startup that develops drugs for obesity and metabolic diseases, launched on Thursday with what it described as a “broad portfolio” of weight-loss treatments that it hopes to bring to market.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News